For example, individuals with a variant of transmembrane 6 superfamily member 2 gene (TM6SF2) exhibit increased liver fat but reduced levels of circulating lipids, representing a metabolically silent variant of NASH [21]. The gene discussed is TM6SF2; the disease is metabolic dysfunction-associated steatohepatitis.